Accellix raised €8.1M in a Series D+ round in Oct 2020. The company is based in Jerusalem, Israel. Investors in the round: bioMerieux. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
